Citations

Showing 10 of 108083 citations.

Authors’ reply to: “Neuropathologic findings in COVID-19 patients should be correlated with clinical neurologic abnormalities”
Eschbacher, Kathryn L. , Larsen, Rachel A. , Reichard, R. Ross

Mayo Clinic

Journal of Neuropathology & Experimental Neurology | January 10, 2023 | Volume: 82 | Issue: 3 | Pages: 278-279

10.1093/jnen/nlac129 | PMID 36625551 Get It

Genomic markers of recurrence risk in atypical meningioma following gross total resection
Vaubel, Rachael A. , Weiskittel, Taylor M. , Jenkins, Sarah M. , Dasari, Surendra , Uhm, Joon H. , Brown, Paul D. , Gompel, Jamie J. Van , Jenkins, Robert B. , Kipp, Benjamin R. , Sukov, William R. , Weiskittel, Taylor M , Van Gompel, Jamie J , Kipp, Benjamin , Sukov, William , Giannini, Caterina , Raghunathan, Aditya , Vaubel, Rachael A , Kumar, Rahul , Lachance, Daniel Honore , Giannini, Caterina , Johnson, Derek R. , Raghunathan, Aditya

Mayo Clinic

Neuro-Oncology Advances | January 10, 2023 | Volume: 5 | Issue: 1 | Pages: No page available

10.1093/noajnl/vdad004 | PMID 36845294 Get It

AbstractBackgroundMeningiomas are the most common primary central nervous system (CNS) tumor in adults and CNS World Health Organization grade 2 (atypical) meningiomas show an intermediate risk of recurrence/progression. Molecular parameters are needed to better inform management following gross total resection (GTR).MethodsWe performed comprehensive genomic analysis of tumor tissue from 63 patients who underwent radiologically confirmed GTR of a primary grade 2 meningioma, including a CLIA-certified target next-generation sequencing panel (n = 61), chromosomal microarray (n = 63), genome-wide methylation profiling (n = 62), H3K27me3 immunohistochemistry (n = 62), and RNA-sequencing (n = 19). Genomic features were correlated with long-term clinical outcomes (median follow-up: 10 years) using Cox proportional hazards regression modeling and published molecular prognostic signatures were evaluated.ResultsThe presence of specific copy number variants (CNVs), including -1p, -10q, -7p, and -4p, was the strongest predictor of decreased recurrence-free survival (RFS) within our cohort (P < .05). NF2 mutations were frequent (51%) but did not show a significant association with RFS. DNA methylation-based classification assigned tumors to DKFZ Heidelberg benign (52%) or intermediate (47%) meningioma subclasses and was not associated with RFS. H3K27 trimethylation (H3K27me3) was unequivocally lost in 4 tumors, insufficient for RFS analysis. Application of published integrated histologic/molecular grading systems did not improve prediction of recurrence risk over the presence of -1p or -10q alone.ConclusionsCNVs are strong predictors of RFS in grade 2 meningiomas following GTR. Our study supports incorporation of CNV profiling into clinical evaluation to better guide postoperative patient management, which can be readily implemented using existing, clinically validated technologies.
Prognostic factors in resected pulmonary carcinoid tumors: A retrospective study with 10 years of follow‑up
Du, Lin , Ernani, Vinicius , Jaroszewski, Dawn E. , Cassivi, Steven D., Beamer, Staci E. , Santos, Pedro Reck dos , Wigle, Dennis A. , Sun, Daqiang , Shen, K. Robert , Liu, Alex, Schild, Steven E. , Luo, Yung-Hung, Wampfler, Jason A. , Santos, Pedro A. Reck dos, Wigle, Dennis, Santos, Pedro Augusto Reck Dos , Liu, Alex C.H. , Luo, Yung‐Hung , Yang, Ping

Mayo Clinic

Oncology Letters | January 10, 2023 | Volume: 25 | Issue: 2 | Pages: No page available

10.3892/ol.2023.13666 | PMID 36742364 Get It

Robotic-Assisted Surgery for Pelvic Organ Prolapse: Sacrocolpopexy and Beyond
Linder, Brian J. , Occhino, John A. , Linder, Brian J

Mayo Clinic

Journal of Gynecologic Surgery | January 10, 2023 | Volume: 39 | Issue: 1 | Pages: 25-29

10.1089/gyn.2022.0119 Get It

Diagnosis of Alzheimer’s disease and tauopathies on whole slide histopathology images using a weakly supervised deep learning algorithm
Martin, Nicholas B. , Castanedes‐Casey, Monica , Hwang, Tae Hyun , Koga, Shunsuke , Koga, Shunsuke , Kim, Minji , Sekiya, Hiroaki , Dickson, Dennis W.

Mayo Clinic

No container title available | January 10, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2459626/v1 Get It

Abstract Neuropathological assessment at autopsy is the gold standard for diagnosing neurodegenerative disorders. We aimed to develop a pipeline for diagnosing Alzheimer's disease and other tauopathies, including corticobasal degeneration, globular glial tauopathy, Pick’s disease, and progressive supranuclear palsy. We used deep learning (DL)-based approach called clustering-constrained-attention multiple instance learning (CLAM) on whole slide images (WSIs) of tau immunohistochemistry in three brain regions from 120 patients. We also augmented gradient-weighted class activation mapping (Grad-CAM) to the model for visualizing cellular-level evidence in the model’s decisions. The model using the sections of cingulate and superior frontal gyri achieved the highest area under the curve (0.970±0.037) and diagnostic accuracy (0.873±0.087). Grad-CAM showed the highest attention in known pathognomonic tau lesions for each disease (e.g., Pick bodies for Pick’s disease). Our findings supported the feasibility of the DL-based approach for the classification task on WSIs, which encouraged further investigation, especially focusing on clinicopathological correlation studies.
A phase II study of combination daunorubicin, cytarabine (Ara‐c), and nilotinib (TAsigna) (DATA) in patients newly diagnosed with acute myeloid leukemia with KIT expression
Al‐Kali, Aref , Atherton, Pamela J. , Palmer, Jeanne , Patnaik, Mrinal M. , Begna, Kebede H. , Gangat, Naseema , Hashmi, Shahrukh K. , He, Rong , Litzow, Mark R. , Atherton, Pamela, Patnaik, Mrinal , Begna, Kebede , Gangat, Naseema , Hashmi, Shahrukh, He, Rong , Litzow, Mark R. , Tibes, Raoul , Alkhateeb, Hassan B.

Mayo Clinic

American Journal of Hematology | January 10, 2023 | Volume: 98 | Issue: 3 | Pages: 472-480

10.1002/ajh.26831 | PMID 36625066 Get It

AbstractAcute myeloid leukemia (AML) is a challenging cancer in terms of achieving and maintaining long‐duration remissions. Many novel therapies have been added to the standard regimen (combining cytarabine and anthracycline “7 + 3”) to achieve such goals. Nilotinib is an oral multikinase inhibitor that is active against KIT tyrosine kinase, an important stem cell target. In this trial, we combined nilotinib with 7 + 3 induction (daunorubicin 60 mg/m2), high‐dose cytarabine consolidation, and subsequently, if the patient was a candidate, for 2 years' maintenance therapy in patients with AML and KIT (CD117) expression. Patients were allowed to proceed to allogeneic hematopoietic cell transplantation (HCT) if deemed necessary. Our primary goal was increased complete remission rate with this combination. Thirty‐four patients (with a median age 58.5 years) were enrolled on a single‐arm phase II bi‐institutional study; 21 (62%) patients achieved remission. The complete remission rate was 78% in evaluable patients. Thirteen of 34 (38%) patients had allogeneic HCT, all thirteen of which are still alive (100%). Common (>20%) grade 3 non‐hematological toxicities included febrile neutropenia, hypophosphatemia, elevated liver enzymes, and hypertension. Only one patient (3%) died in induction due to liver failure, which was thought secondary to daunorubicin. Our current study reveals good outcomes in patients who received HCT and may warrant a larger study to confirm our findings in that specific population.
Changes in Elbow Stress and Ball Velocity During Reduced Effort Pitching: A Marker-Based Motion Capture Analysis
Fiegen, Anthony P., Nezlek, Stuart, Loushin, Stacy R. , Christoffer, Dan, Verhoeven, Martijn, Nezlek, Stuart P, Fiegen, Anthony P. , Kaufman, Kenton R. , Camp, Christopher L.

Mayo Clinic

The American Journal of Sports Medicine | January 10, 2023 | Volume: 51 | Issue: 3 | Pages: 779-785

10.1177/03635465221144020 | PMID 36625428 Get It

Background: Baseball pitchers often participate in throwing programs that involve throwing at reduced effort levels to gradually increase the amount of stress experienced across the elbow. It is currently unknown how reduced effort pitching compares with maximum effort with respect to elbow stress and ball velocity. Purpose/Hypothesis: The purpose was to determine the correlation between elbow stress and ball velocity with reduced effort pitching. We hypothesized that decreased perceived effort would disproportionately correlate with elbow stress and ball velocity. Study Design: Descriptive laboratory study. Methods: Ten healthy male high school baseball pitchers threw 5 pitches from a regulation pitching mound at 3 effort levels: maximum effort, 75% effort, and 50% effort. Elbow stress, specifically elbow varus torque, was calculated for all pitches using a validated marker-based 3-dimensional motion capture system. Ball velocity was measured using a Doppler radar gun. Intrathrower variability was calculated for each effort level. Results: Elbow stress and ball velocity decreased with reduced effort throws ( P < .001 and P = .003, respectively). However, the reductions in elbow stress and ball velocity were not proportional. At 75% effort throws, elbow stress measured 81% (intraclass correlation coefficient [ICC], 0.95), and ball velocity measured 90% (ICC, 0.80) of maximum, respectively. At 50% effort throws, elbow stress measured 75% (ICC, 0.93), and ball velocity measured 85% (ICC, 0.87) of maximum. Intrathrower reliability was excellent for elbow stress and ball velocity, with all ICCs ≥0.80. Conclusion: Pitching at a reduced effort level resulted in decreased elbow stress and ball velocity. However, for every 25% reduction in perceived effort, elbow stress decreased by a mean 13%, and ball velocity decreased 7.5%. When baseball pitchers attempt to throw at a reduced effort of maximum, throwing metrics do not decrease proportionately. Clinical Relevance: While pitching at a reduced effort of maximum decreases elbow stress and ball velocity, the decrease is not proportional, subjecting the elbow to more stress than intended. This has significant clinical importance to pitchers, coaches, and medical professionals in the setting of injury prevention and return to sports.
Adapting Group CBT-I for Telehealth-to-Home With Military Veterans in Primary Care
Arizmendi, Brian J. , Gress‐Smith, Jenna L., Krieg, Christina, Waddell, Jack T.

Mayo Clinic

Journal of Primary Care & Community Health | January 10, 2023 | Volume: 14 | Issue: No issue available | Pages: No page available

10.1177/21501319221143722 | PMID 36625248 Get It

Utilization of telehealth modalities to provide cognitive and behavioral therapies is rapidly increasing. Limitations to access to care can prohibit individuals from getting the care they need, especially evidence-based treatments. In the U.S., Veterans are a population in great need of accessible and high-quality evidence-based psychotherapy for insomnia, as it often co-occurs with other common syndromes such as depression and PTSD. Cognitive Behavioral Therapy for Insomnia (CBT-I) offers effective treatment for insomnia and can be delivered via telehealth and in a group format to greatly increase availability and accessibility. To date, however, few programs exist offering telehealth-to-home CBT-I, fewer still are offered in a primary care setting, and none to our knowledge are offered in group format. We examine the feasibility and efficacy of a fully telehealth-to-home (TTH) group CBT-I pilot program in primary care and compare primary outcomes to those seen in a face-to-face (F2F) format as well as meta-analytic studies of group CBT-I. Primary endpoints, as typically defined such as sleep efficiency (SE) and scores on the insomnia severity index (ISI) appear comparable to those seen in F2F groups in our clinic, and to outcomes seen in the literature. We discuss challenges and strategies for successful implementation of such a program in integrated primary care to increase access and availability of this evidence-based treatment.
Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures
Mokgautsi, Ntlotlang , Kuo, Yu‐Cheng, Huang, Yan‐Jiun , Chen, Chien-Hsin, Wu, Alexander T.H. , Huang, Hsu-Shan , Mukhopadhyay, Debabrata , Wu, Alexander T H , Huang, Hsu-Shan , Mukhopadhyay, Debabrata

Mayo Clinic

Cells | January 10, 2023 | Volume: 12 | Issue: 2 | Pages: 266

10.3390/cells12020266 | PMID 36672201 Get It

Colorectal cancer (CRC) is one of the most common cancers, and it frequently metastasizes to the liver and lymph nodes. Despite major advances in treatment modalities, CRC remains a poorly characterized biological malignancy, with high reported cases of deaths globally. Moreover, cancer stem cells (CSCs) and their microenvironment have been widely shown to promote colon cancer development, progression, and metastasis. Therefore, an understanding of the underlying mechanisms that contribute to the maintenance of CSCs and their markers in CRC is crucial in efforts to treat cancer metastasis and develop specific therapeutic targets for augmenting current standard treatments. Herein, we applied computational simulations using bioinformatics to identify potential theranostic markers for CRC. We identified the overexpression of vascular endothelial growth factor-α (VEGFA)/β-catenin/matrix metalloproteinase (MMP)-7/Cluster of Differentiation 44 (CD44) in CRC to be associated with cancer progression, stemness, resistance to therapy, metastasis, and poor clinical outcomes. To further investigate, we explored in silico molecular docking, which revealed potential inhibitory activities of LCC-21 as a potential multitarget small molecule for VEGF-A/CTNNB1/MMP7/CD44 oncogenic signatures, with the highest binding affinities displayed. We validated these finding in vitro and demonstrated that LCC-21 inhibited colony and sphere formation, migration, and invasion, and these results were further confirmed by a Western blot analysis in HCT116 and DLD-1 cells. Thus, the inhibitory effects of LCC-21 on these angiogenic and onco-immunogenic signatures could be of translational relevance as potential CRC biomarkers for early diagnosis.